REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Booming Biotechnology Industry Continues to Impress Investors in 2012
July 12, 2012
Five Star Equities Provides Stock Research on Achillion and AVI BioPharma Read More
from Marketwired News Releases
AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today
July 12, 2012
Enacts Reverse Stock Split to Strengthen Financial Base; Reaffirms Commitment to Accelerate Development of First-in-Class RNA-Based Therapies for Serious and Life-Threatening Rare and Infectious... Read More
from Marketwired News Releases
AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference
July 06, 2012
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
June 01, 2012
from Marketwired News Releases
Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release
May 11, 2012
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by FinancialNewsMedia.com Read More
from Marketwired News Releases
AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments
May 10, 2012
from Marketwired News Releases
U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit
May 04, 2012
The Paragon Report Provides Stock Research on AVI BioPharma and XOMA Read More
from Marketwired News Releases
AVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference Call
May 03, 2012
from Marketwired News Releases
AVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 AAN Annual Meeting
April 25, 2012
Previously Reported Data Demonstrated Study Met Primary Endpoint Read More
from Marketwired News Releases
HRDN, LZEN, AVII and BONU are the Daily Market Movers for April 9th from OTCPicks.com
April 09, 2012
from EmailWire.Com Press Releases
AVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Compared to Placebo in Phase IIb Trial for the Treatment of Duchenne Muscular
April 02, 2012
from Marketwired News Releases
AVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase IIb DMD Study
March 30, 2012
from Marketwired News Releases
Data From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases
March 30, 2012
from Marketwired News Releases
AVI BioPharma to Present Company Overview at the 11th Annual Needham Healthcare Conference
March 27, 2012
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI BioPharma Announces Late-Breaker Oral Presentation of Phase IIb DMD Study at 2012 AAN Annual Meeting in April
March 12, 2012
from Marketwired News Releases
AVI BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results and Recent Corporate Developments
March 01, 2012
from Marketwired News Releases
AVI BioPharma Announces FDA Approval to Proceed With a Modified Dosing of AVI-6003 for Treatment of Marburg Virus
February 28, 2012
AVI-7288, a Component of AVI-6003, Shows Efficacy Results in Standalone Treatment of Non-Human Primate Studies Read More
from Marketwired News Releases
AVI BioPharma to Present Company Overview at the Cowen and Company 32nd Annual Health Care Conference
February 27, 2012
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results and Corporate Update Conference Call
February 23, 2012
from Marketwired News Releases
AVI BioPharma Regains NASDAQ Compliance
February 22, 2012
from Marketwired News Releases
Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based Therapeutics for Treatment of Ebola and Marburg Viruses
February 09, 2012
Data and Safety Monitoring Board Recommends Proceeding With Multiple Ascending Dose Studies Read More
from Marketwired News Releases
AVI BioPharma to Present Company Overview at the 14th Annual BIO CEO & Investor Conference
February 02, 2012
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI BioPharma Data Safety Monitoring Board Reports No Safety Concerns Identified in Phase IIb DMD Clinical Trial, Recommends Continuation of Trial
January 04, 2012
from Marketwired News Releases
AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
December 14, 2011
from Marketwired News Releases
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
December 09, 2011
New Hire Is Part of Organizational Restructuring Focused on Improving Operational Efficiencies Read More
from Marketwired News Releases
AVI BioPharma to Present Company Overview at the Piper Jaffray Health Care Conference
November 22, 2011
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI Enters Into Collaborations for the Development of Two Additional Exon-Skipping Products for Duchenne Muscular Dystrophy (DMD)
November 15, 2011
Collaborations Represent Key Inflection Point in AVI's Progress in Developing Treatments for Broader DMD Population Read More
from Marketwired News Releases
Promising Stocks Trading Under One Dollar by Mega Stock Picks: AVII, PEIX, CXM, FBC, SATC
November 12, 2011
from EmailWire.Com Press Releases
AVI BioPharma to Present Company Overview at the Lazard Capital Markets 8th Annual Healthcare Conference
November 08, 2011
Webcast Accessible via AVI Website Read More
from Marketwired News Releases
AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments
November 03, 2011
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here